| CKD without diabetes N = 1747 | CKD with diabetes N = 698 | p-value |
---|---|---|---|
Gender, male | 1047 (59.9%) | 461 (66.0%) | 0.006 |
CKD stage | Â | Â | <Â 0.001 |
 CKD-3 | 662 (37.9%) | 288 (41.3%) |  |
 CKD-4/5 | 551 (31.5%) | 256 (36.7%) |  |
 RTT | 534 (30.6%) | 154 (22.1%) |  |
Age [years] | 59.0 [48.0;67.0] | 65.0 [56.0;70.0] | <Â 0.001 |
Current smoker | 967 (55.4%) | 404 (57.9%) | 0.275 |
Hypertension | 1554 (89.0%) | 673 (96.4%) | <Â 0.001 |
25-OH vitamin D [ng/ml] | 15.4 [11.4;19.6] | 13.8 [10.4;18.5] | <Â 0.001 |
eGFR [ml/min per 1.73 m2] | 31.6 [20.9;44.3] | 31.7 [21.5;44.2] | 0.812 |
Glucose [mg/dl] | 92.0 [85.0;101] | 133 [108;164] | <Â 0.001 |
Total cholesterol [mg/dl] | 177 [153;205] | 171 [143;197] | <Â 0.001 |
HDL cholesterol [mg/dl] | 48.0 [39.0;59.0] | 44.0 [36.0;53.9] | <Â 0.001 |
LDL cholesterol [mg/dl] | 103 [82.0;123] | 92.0 [71.4;113] | <Â 0.001 |
non-HDL cholesterol [mg/dl] | 128 [105;153] | 122 [100;148] | 0.011 |
Triglycerides [mg/dl] | 118 [89.0;162] | 147 [103;205] | <Â 0.001 |
hsCRP [mg/dl] | 1.86 [0.90;4.17] | 2.58 [1.16;5.84] | <Â 0.001 |
Antidiabetic treatment | Â | Â | <Â 0.001 |
 Diet | – | 166 (23.8%) |  |
 Oral hypoglycemic drugs | – | 164 (23.5%) |  |
 Insulin treatment | – | 368 (52.7%) |  |
HbA1c [g/dl] | 5.40 [5.10;5.70] | 6.80 [6.10;7.80] | <Â 0.001 |
Albumin/creatinine ratio mg/g | 89.1 [11.2;384] | 149 [18.6;601] | 0.001 |
Pulse pressure [mmHg] | 56.0 [47.0;69.0] | 68.0 [54.0;81.0] | <Â 0.001 |
Antihypertensive treatment | 1506 (86.2%) | 650 (93.1%) | <Â 0.001 |
Lipid-lowering drugs | 975 (55.8%) | 465 (66.6%) | <Â 0.001 |
Number of plaques | 1.00 [0.00;3.00] | 3.00 [1.00;5.00] | <Â 0.001 |
Presence of any plaque | 1138 (65.1%) | 570 (81.7%) | <Â 0.001 |
Presence of carotid plaques | 901 (51.6%) | 502 (71.9%) | <Â 0.001 |
Carotid plaque [only] | 291 (16.7%) | 165 (23.6%) | <Â 0.001 |
Presence of femoral plaques | 847 (48.5%) | 405 (58.0%) | <Â 0.001 |
Femoral plaque [only] | 237 (13.6%) | 68 (9.74%) | 0.012 |
>Â 2 territories with plaque | 853 (48.8%) | 465 (66.6%) | <Â 0.001 |
Carotid and femoral plaques | 610 (34.9%) | 337 (48.3%) | <Â 0.001 |
Follow-up time [months] | 48.4 [27.1;52.0] | 48.3 [25.7;52.0] | 0.675 |